Plastics technology company unveils project to revolutionize packaging — here's how it can succeed where others have failed
A new project will help implement reusable plastic packaging in multiple countries across Europe.
As explained by Packaging Europe, the plastics technology center AIMPLAS announced the launch of the Buddie-Pack project, which aims "to implement a circular system for the large-scale deployment of reusable plastic packaging."
Examples of products that Packaging Europe provided included "a semi-rigid skin pack for meat distribution (Dawn Meats), semi-rigid catering trays at schools and nursing homes for 1 portion and 8 portions (Ausolan), pre-packed food in supermarkets (Uzaje), and catering trays for takeaway food consumption (Vytal)."
On the one hand, this news gives vibes of "the best way to cut down on plastic is to produce more recyclable plastic" — even though it may never actually get recycled. That could be worse in many ways if the plastic items are made with more plastic and then still get tossed at a similar rate.
If there are single-use items that can become multi-use items, it's generally better to make them with something less polluting such as metal, ceramic, or glass. But if those would be easily damaged or broken, it could be beneficial to use plastic products designed to be reused or recycled — if those who use them actually do so enough to drive down virgin plastic production.
That's a big if without knowing more about how it will play out in practice. But while the Buddie-Pack project is coordinated by the Industrial Technical Center for Plastics and Composites, it's funded by the European Union research and innovation program Horizon Europe, which says it "tackles climate change" and "helps to achieve the UN's Sustainable Development Goals."
The report said 19 partners from six countries have committed to participate in the project, which is set to take place over the next three-and-a-half years.
"The project is anticipated to cut down the production of single-use plastic packaging, reduce water and energy consumption, and avoid the release of microplastics into the oceans," Packaging Europe stated.
Reusable plastic packaging incurs skepticism from many who question the safety and cleanliness of repeatedly using the same products. The Buddie-Pack project plans to address this by analyzing consumer habits and promoting "cleaning solutions to guarantee consumer safety against the possible contamination and ageing of all reusable business cases during their repeated use, and the durability of their functional properties and recyclability," per Packaging Europe.
When you think about a product's packaging, which of these factors is more important to you?
The way it looks
The information it provides
The waste it produces
I don't think about packaging at all
Click your choice to see results and speak your mind.
The project will apply mechanical recycling, which Packaging Europe said is "'the most widely adopted method' for plastic recycling, said to have relatively low energy requirements, minimal infrastructure needs and be highly scalable."
This effort is one of the latest positive steps in the fight to reduce plastic pollution across the world, as many big-name companies have begun lending a hand in hopes of making a difference. For example, ShopRite partnered with TerraCycle to launch a program that provides kiosks for recycling flexible plastic packaging. Similarly, Nestlé expanded its use of innovative paper packaging across major brands to make 95% of its plastic packaging recyclable by the end of this year.
These projects are part of a commitment to help consumers make smarter recycling choices and keep plastics out of landfills, where they can take decades to break down. By reducing our reliance on single-use plastics, we can all contribute to a healthier planet.
Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
06-06-2025
- Yahoo
VSTM Stock Soars 22% in a Month on Ovarian Cancer Combo Drug Approval
Verastem Oncology VSTM shares rallied 22.2% in a month, primarily driven by the FDA approval of the company's novel combination regimen of avutometinib plus defactinib in early May for treating KRAS mutant recurrent low-grade serous ovarian cancer (LGSOC), a rare and distinct type of ovarian cancer. The FDA's decision came well in advance of the originally expected date of June 30, 2025. The approval was granted under the FDA's accelerated approval pathway and is commercialized in the U.S. market as an oral combination co-pack with the two prescription products, known as 'Avmapki Fakzynja Co-Pack.' Following the FDA approval, Avmapki Fakzynja Co-Pack is the first and only FDA-approved treatment for the LGSOC indication. Per Verastem Oncology, the combo offers a much-needed treatment option for patients and sets a new standard of care for women with recurrent LGSOC with a KRAS mutation. Full approval of the product for this use depends on the detailed evidence of clinical benefit in the follow-up phase III RAMP 301 confirmatory study, which will evaluate the combination in women with and without a KRAS mutation. Year to date, Verastem Oncology stock has surged 64.8% against the industry's 5.8% decline. Image Source: Zacks Investment Research Please note that the FDA's decision was based on the results from VSTM's phase II RAMP 201 study, which evaluated the combination of Avmapki and Fakzynja in adult patients with measurable KRAS-mutated recurrent LGSOC. Per the data readout, a 44% overall response rate was observed in patients treated with the combo therapy, with an acceptable safety profile. Additionally, the median duration of response ranged from 3.3 to 31.1 months in the KRAS mutant population. The Avmapki/Fakzynja combo enjoys the FDA's Breakthrough Therapy designation for the treatment of patients with recurrent LGSOC after one or more prior lines of therapy, including platinum-based chemotherapy, in the United States. Avutometinib alone or in combination with defactinib also enjoys the FDA's Orphan Drug designation for the same indication. Verastem Oncology is also looking to expand the label of its approved avutometinib/defactinib combo therapy beyond LGSOC. Last week, VSTM reported positive updated safety and efficacy results from the phase I/II RAMP 205 study evaluating avutometinib plus defactinib in combination with chemotherapy (gemcitabine and Nab-paclitaxel) for the first-line treatment of metastatic pancreatic ductal adenocarcinoma (PDAC) patients. This has also likely contributed to the stock price rally in the past month. The RAMP 205 study is evaluating 60 patients in five cohorts (12 per cohort) who are receiving one of five dose regimens of avutometinib/defactinib combo with chemotherapy for frontline metastatic PDAC. As of April 25, 2025, patients in the dose level 1 cohort achieved an overall response rate of 83% (eight confirmed and two unconfirmed who remain on treatment). Based on this encouraging outcome, Verastem Oncology selected dose level 1 as the recommended phase II dose. Additionally, it was found that the dose level 1 showed the best response, and overall, 92% of patients across all dose levels achieved tumor shrinkage. The safety profile of the avutometinib/defactinib combo was acceptable across all the treatment cohorts and no new safety signals were identified. Verastem Oncology is currently gearing up to initiate a registrational phase III front-line metastatic PDAC study in 2026. Apart from these indications, the company is simultaneously evaluating avutometinib and defactinib in combination with a KRAS G12C inhibitor, sotorasib, for treating non-small cell lung cancer in a separate mid-stage study. Verastem, Inc. price-consensus-chart | Verastem, Inc. Quote Verastem Oncology currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the biotech sector are Bayer BAYRY, Lexicon Pharmaceuticals LXRX and Amarin AMRN, each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. In the past 60 days, estimates for Bayer's earnings per share have increased from $1.19 to $1.25 for 2025. During the same time, earnings per share have increased from $1.28 to $1.31 for 2026. Year to date, shares of Bayer have gained 45.3%. BAYRY's earnings beat estimates in one of the trailing four quarters, matched twice and missed on the remaining occasion, the average negative surprise being 13.91%. In the past 60 days, estimates for Lexicon's loss per share have narrowed from 37 cents to 32 cents for 2025. During the same time, loss per share estimates for 2026 have narrowed from 35 cents to 31 cents. Year to date, shares of LXRX have lost 6.6%. LXRX's earnings beat estimates in three of the trailing four quarters and missed the same on the remaining occasion, delivering an average surprise of 11.97%. In the past 60 days, estimates for Amarin's loss per share have narrowed from $5.33 to $3.48 for 2025. During the same time, loss per share estimates for 2026 have narrowed from $4.13 to $2.67. Year to date, shares of AMRN have gained 17.1%. AMRN's earnings beat estimates in two of the trailing four quarters, matched once and missed the same on the remaining occasion, delivering an average surprise of 29.11%. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bayer Aktiengesellschaft (BAYRY) : Free Stock Analysis Report Lexicon Pharmaceuticals, Inc. (LXRX) : Free Stock Analysis Report Amarin Corporation PLC (AMRN) : Free Stock Analysis Report Verastem, Inc. (VSTM) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
Yahoo
05-06-2025
- Yahoo
The UPS Store Opens in Steilacoom, WA -- Offers to Buy Out Existing Mailbox Contracts
Locally owned and operated, The UPS Store #7972 brings 24/7 mailboxes, shipping, and small business support to the Steilacoom community. LAKEWOOD, Wash., June 5, 2025 /PRNewswire/ -- A new UPS Store® has opened in Steilacoom, providing local residents, remote professionals, and small businesses with reliable shipping, printing, and mailbox services. Located at 8520 Steilacoom Boulevard SW, Suite 101A, the store is locally owned by Reggie Matto and operated by Preet Minhas. As part of its grand opening, The UPS Store Steilacoom is offering to buy out mailbox contracts from other providers, making it easier for customers to upgrade to a secure, professional mailbox service with enhanced access and convenience. "We know people are tied into contracts, but we're willing to earn their business," said owner Reggie Matto. "Our mailbox service offers a real street address, 24/7 access, and delivery alerts—perfect for busy professionals, frequent online shoppers, or anyone who wants more control over their mail." "We're not just a shipping center," added operator Preet Minhas. "We're here to serve the needs of this community—whether you're a new resident, a remote worker, or building a business from your kitchen table." Key Services Offered: Mailbox rentals with access 7 days/week, street address, and package notifications Shipping and receiving via UPS, USPS, FedEx, DHL, and Amazon Access Point Full-service packing with The UPS Store Pack & Ship Guarantee® Printing, copying, scanning, shredding, and faxing Notary and passport photo services Business Consulting Who It's For: Home-based businesses and entrepreneurs needing a professional mailing address Remote and hybrid workers who want secure access to personal or work-related mail New movers looking for a stable mailbox while settling in Frequent online shoppers who want to avoid missed deliveries or porch theft Grand Opening Mailbox Offer: Customers who bring in an active mailbox contract from another provider will receive a buyout credit and complimentary setup fee when switching to The UPS Store Steilacoom. Switch today and we will pay off your remaining mailbox contract and waive your setup fee—no questions asked. Offer valid in-store only. Store InformationThe UPS Store #79728520 Steilacoom Blvd SW, Suite 101ALakewood, WA 98498Phone: (253) 433-3849Email: store7972@ About The UPS Store®The UPS Store® network includes more than 5,000 independently owned locations across the United States, offering small business services, printing, shipping, and secure mailbox solutions under one roof. Media ContactJustin (801) 666-5973Email: justin@ View original content to download multimedia: SOURCE The UPS Store - Steilacoom (Store #7972) Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Business Wire
02-06-2025
- Business Wire
The European Equity Fund, Inc. Announces Portfolio Manager Changes
NEW YORK--(BUSINESS WIRE)--The European Equity Fund, Inc. (NYSE: EEA) (the 'Fund') announced today that Hansjoerg Pack will replace Juan Barriobero as the Fund's portfolio manager effective July 1, 2025. Effective July 1, 2025, Mr. Barriobero, who has served as the Fund's portfolio manager since 2020, will replace Frank Kuemmet as the Fund's deputy portfolio manager. Mr. Pack joined DWS in 1997 and has extensive portfolio management experience, including multiple global equity strategies with significant exposure to European markets. He also has experience in managing funds with significant allocations to German small and mid-cap equity securities, including DWS Aktien Strategie Deutschland (with current net assets of over EUR 2 billion) from 2016 to the present. Mr. Pack received a BA in Business Administration from Sheffield Hallam University; a Master's Degree in Economics ("Diplom-Volkswirt") from University of Duisburg-Essen; and is a CEFA - Certified European Financial Analyst. Important Information The European Equity Fund, Inc. is diversified and primarily focuses its investments in equity securities of issuers domiciled in Europe, thereby increasing its vulnerability to developments in that region. Investing in foreign securities, particularly of emerging markets, presents certain risks, such as currency fluctuations, and risks of currency and capital controls, political and economic changes, and market risks. Any fund that concentrates in a particular segment of the market or a particular geographical region will generally be more volatile than a fund that invests more broadly. The shares of most closed-end funds, including the Fund, are not continuously offered. Once issued, shares of closed-end funds are bought and sold in the open market through a stock exchange. Shares of closed-end funds frequently trade at a discount to net asset value. The price of a fund's shares is determined by a number of factors, several of which are beyond the control of the fund. Therefore, a fund cannot predict whether its shares will trade at, below, or above net asset value. War, terrorism, sanctions, economic uncertainty, trade disputes, public health crises and related geopolitical events have led, and, in the future, may lead to significant disruptions in US and world economies and markets, which may lead to increased market volatility and may have significant adverse effects on the funds and their investments. This press release shall not constitute an offer to sell or a solicitation to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer or solicitation or sale would be unlawful prior to registration or qualification under the laws of such state or jurisdiction. Past performance is no guarantee of future results. NOT FDIC/ NCUA INSURED • MAY LOSE VALUE • NO BANK GUARANTEE NOT A DEPOSIT • NOT INSURED BY ANY FEDERAL GOVERNMENT AGENCY DWS Distributors, Inc. 222 South Riverside Plaza Chicago, IL 60606-5808 Tel (800) 621-1148 © 2025 DWS Group GmbH & Co. KGaA. All rights reserved The brand DWS represents DWS Group GmbH & Co. KGaA and any of its subsidiaries such as DWS Distributors, Inc. which offers investment products or DWS Investment Management Americas, Inc. and RREEF America L.L.C. which offer advisory services. (R-106206) (05/25)